" class="no-js "lang="en-US"> Jonathan Van-Tam Archives - Medtech Alert
Wednesday, October 01, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

UK's Most Vulnerable People to Receive Life-saving COVID-19 Treatments in the Community

Thousands of the UK’s most vulnerable people will be among the first in the world to […]

UK Government Secures Groundbreaking COVID-19 Antivirals

Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more